Literature DB >> 10354200

Physicochemical and functional modifications induced by obesity on human erythrocyte membranes.

E Faloia1, G G Garrapa, D Martarelli, M A Camilloni, G Lucarelli, R Staffolani, F Mantero, G Curatola, L Mazzanti.   

Abstract

BACKGROUND: Na+,K(+)-ATPase activity was evaluated in relation to membrane composition and molecular organization in erythrocyte membranes from obese patients by the amphyphylic molecule 6-dodecanoyl-2-dimethylamino-naphthalene (Laurdan). Its possible relationship with fat distribution and hyperinsulinaemia was also investigated.
DESIGN: Subjects were 10 obese men (OM), 12 women with subcutaneous obesity (FSO), 10 women with abdominal obesity (FAO) and 41 healthy lean subjects, 26 women (FC) and 15 men (MC). An oral glucose tolerance test was administered to all subjects to evaluate insulin secretion and glucose tolerance.
RESULTS: Na+,K(+)-ATPase activity was increased in all obese patients. Values were higher in FSO and FAO than in FC (with FAO greater than FSO) and in OM than in MC. The erythrocyte membrane cholesterol-to-phospholipid ratio was increased in obese patients and was significantly different in FSO patients compared with FC. The erythrocyte membrane protein-to-phospholipid ratio was also increased in all obese subjects, reaching statistical significance only in FSO vs. FC. The liquid crystalline phase, as tested by Laurdan generalized polarization (GP), was decreased in obese patients, indicating the presence of greater molecular environmental order; all patients groups showed lower GP values than control subjects, but only FAO reached statistical significance compared with FC. There was no evident correlation between membrane Na+,K(+)-ATPase activity and insulin levels, nor did membrane composition and properties show any evident relationship with insulin levels.
CONCLUSION: Both increased Na+,K(+)-ATPase activity and altered fluidity and lipid composition were observed in the erythrocyte membrane of all obese patients. These findings are in line with previous observations by our group and indicate that the changes in Na+,K(+)-ATPase activity observed in obese patients could be related to changes in plasma membrane organization and composition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354200     DOI: 10.1046/j.1365-2362.1999.00458.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  Biomechanical properties of red blood cells in health and disease towards microfluidics.

Authors:  Giovanna Tomaiuolo
Journal:  Biomicrofluidics       Date:  2014-09-17       Impact factor: 2.800

2.  AdipoRon Attenuates Wnt Signaling by Reducing Cholesterol-Dependent Plasma Membrane Rigidity.

Authors:  Michael L Salinas; Natividad R Fuentes; Rachel Choate; Rachel C Wright; David N McMurray; Robert S Chapkin
Journal:  Biophys J       Date:  2019-09-16       Impact factor: 4.033

3.  Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation.

Authors:  Ryan G Holzer; Eek-Joong Park; Ning Li; Helen Tran; Monica Chen; Crystal Choi; Giovanni Solinas; Michael Karin
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

4.  Estimating in vivo potassium distribution and fluxes with stable potassium isotopes.

Authors:  Jang H Youn; Young Taek Oh; Stefania Gili; Alicia A McDonough; John Higgins
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-26       Impact factor: 4.249

Review 5.  Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Authors:  Chiranjeevi Peetla; Andrew Stine; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

6.  LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition.

Authors:  Xin Rong; Carolyn J Albert; Cynthia Hong; Mark A Duerr; Brian T Chamberlain; Elizabeth J Tarling; Ayaka Ito; Jie Gao; Bo Wang; Peter A Edwards; Michael E Jung; David A Ford; Peter Tontonoz
Journal:  Cell Metab       Date:  2013-11-05       Impact factor: 27.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.